Camila Yamashita

Camila Yamashita

Auto-generated profile, based on publicly available information

Camila Yamashita

Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in Applied Food Research
Verified
Journal Article
Open access
MNMarcela Tiemi Nogueira
Marcela Tiemi Nogueira
LCLetícia Rustici Chica
Letícia Rustici Chica
CYCamila Yamashita
Camila Yamashita
NNNatalie Stephanie Sawada Nunes
Natalie Stephanie Sawada Nunes
IMIzabel Cristina Freitas Moraes
Izabel Cristina Freitas Moraes
IBIvanise Guilherme Branco
Ivanise Guilherme Branco

23 September 2024 in Food Chemistry Advances
Verified
Journal Article
Open access
LCLetícia Rustici Chica
Letícia Rustici Chica
CYCamila Yamashita
Camila Yamashita
NNNatalie Stephanie Sawada Nunes
Natalie Stephanie Sawada Nunes
ANArthur Torres Negreiros
Arthur Torres Negreiros
IMIzabel Cristina Freitas Moraes
Izabel Cristina Freitas Moraes
IBIvanise Guilherme Branco
Ivanise Guilherme Branco

28 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSushila Maharjan
Sushila Maharjan
CYCamila Yamashita
Camila Yamashita
CLCheng Pau Lee
Cheng Pau Lee
AZAlejandro Villalobos Zepeda
Alejandro Villalobos Zepeda
AFAna Karen Michel Farias
Ana Karen Michel Farias
Yu Shrike ZhangYu Shrike Zhang
Yu Shrike Zhang
Cellular agriculture is an emerging field that leverages stem cell biology, biotechnology, and tissue engineering to produce meat and other agricultural products through cell culture techniques. One of the most promising methods within this domain is three-dimensional (3D) bioprinting, which allows for precise layering of cells to form sophisticated structures. In this study, we introduce fully automated chaotic bioprinting with a custom-built extrusion setup taking advantage of an integrated Kenics static mixer printhead to create plant and animal cell-based hybrid noodles. These bioprinted hybrid noodles are made of approximately 30–40% unicellular plant cells (Chlamydomonas or Chlorella microalgae) and 60–70% muscle cells (C2C12 or chicken myoblasts). We further 3D-bioprinted aesthetically appealing hybrid food products of various shapes and sizes, where their textures, nutritional contents, and cooking behaviors are evaluated. This proof-of-concept study demonstrates that 3D bioprinting can reliably produce a distinct category of plant- and animal cell-based hybrid foods and highlights opportunities to create complex culinary designs and explore diverse nutritional profiles with precision and efficiency.